APLU Member COVID-19 Research Initiatives

Penn State is looking to address key knowledge gaps with research focused on improving prevention, diagnostics, treatment, infection control practices, and public health policies.

As the COVID-19 pandemic continues its global spread, researchers at Indiana University are working on myriad aspects of the response.

University of Wisconsin-Madison researchers respond to COVID-19 by studying the virus from different angles and disciplines.

From students supporting frontline workers to researchers developing potential treatments and vaccines, here are just some of the ways the UBC community is doing its part to combat the global pandemic.

Students, faculty and staff across the University of Kansas are actively engaged in responding to the COVID-19 pandemic’s effect on the region and society.

University of Pittsburgh School of Medicine scientists announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic.

All 14 UT institutions along with their faculty, researchers, health care providers, staff and students are meeting the challenges of COVID-19 with ingenuity, compassion and perseverance.

The University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) has been awarded $23 million to fast-track efforts to develop a COVID-19 vaccine.

The University of Texas at Austin is committed to making an impact as we face the COVID-19 pandemic.

The University of Virginia is mobilizing its resources and researchers to find a test and a vaccine for COVID-19, treat the ill, track the COVID-19 globally, and analyze the crisis through the lens of history, politics, economics, business, law and more.